Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

The cost of decoding our genetic makeup has plummeted. Just because it’s affordable doesn’t necessarily mean it’s worth doing ...

The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid ...

When it comes to critical care for newborns, being able to act fast is of the utmost importance, which is why this new DNA tech is so important.

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

Cornell researchers have found that a new DNA sequencing technology can be used to study how transposons move within and bind to the genome. Transposons play critical roles in immune response, ...

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...

A national study, led by researchers at Tufts Medical Center, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also affect other areas of the body like the spine, brain or kidneys.

Two University of Wisconsin researchers Edgar Spalding and Takeshi Yoshihara recently published a study concluding that there ...